Literature DB >> 18458264

Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?

Adrian F Hernandez1, Robert A Harrington.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458264      PMCID: PMC2335195          DOI: 10.1503/cmaj.080370

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  22 in total

1.  Hierarchical modeling: its time has come.

Authors:  Elizabeth DeLong
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

2.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

3.  Is improved survival a class effect of angiotensin-converting enzyme inhibitors?

Authors:  Sean Hennessy; Stephen E Kimmel
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

4.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

5.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 6.  A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients.

Authors:  M E Khalil; A W Basher; E J Brown; I A Alhaddad
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

7.  The way of the future.

Authors:  E A Stead
Journal:  Trans Assoc Am Physicians       Date:  1972

8.  Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

Authors:  Louise Pilote; Michal Abrahamowicz; Eric Rodrigues; Mark J Eisenberg; Elham Rahme
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

9.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Authors:  K M Fox
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

View more
  4 in total

1.  Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study.

Authors:  Abhishek S Chitnis; Rajender R Aparasu; Hua Chen; Mark E Kunik; Paul E Schulz; Michael L Johnson
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

2.  Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response.

Authors:  Friederike Klempin; Valentina Mosienko; Susann Matthes; Daniel C Villela; Mihail Todiras; Josef M Penninger; Michael Bader; Robson A S Santos; Natalia Alenina
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

3.  Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.

Authors:  Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary N Walsh; Clyde W Yancy
Journal:  J Am Heart Assoc       Date:  2012-02-20       Impact factor: 5.501

4.  Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) P. Karst.

Authors:  Nurhuda Mohamad Ansor; Noorlidah Abdullah; Norhaniza Aminudin
Journal:  BMC Complement Altern Med       Date:  2013-10-04       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.